Evidence map›Paper›PMID 42426435›Full record

ArticleInflammopharmacology2026

Safranal protects neurons against amyloid beta-induced toxicity.

Deepali Singh, Sharmistha Panda, Chitra Mohinder Singh Singal, Hriday Shanker Pandey, Pankaj Seth, Shiv Kumar Sharma

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Deepali SinghNational Brain Research Centre, Manesar, Haryana, 122052, India.
Sharmistha PandaNational Brain Research Centre, Manesar, Haryana, 122052, India.
Chitra Mohinder Singh SingalNational Brain Research Centre, Manesar, Haryana, 122052, India.
Hriday Shanker PandeyNational Brain Research Centre, Manesar, Haryana, 122052, India.
Pankaj SethNational Brain Research Centre, Manesar, Haryana, 122052, India.
Shiv Kumar SharmaNational Brain Research Centre, Manesar, Haryana, 122052, India. shiv.ks@cbcs.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid beta is critically involved in the initiation and progression of Alzheimer's disease (AD). This peptide is neurotoxic. It can cause cell death by acting on neurons. It can also cause neuronal cell death by acting on glial cells, resulting in the production of toxic and inflammatory molecules, which eventually cause neurotoxicity. In this study, we show that safranal, a compound present in the spice saffron, reduces reactive oxygen species (ROS) and nitric oxide (NO) levels from hippocampal neuronal cells, HT22, treated with oligomeric amyloid beta. It reduces alteration in mitochondrial membrane potential induced by amyloid beta. Safranal shows protective effects against amyloid beta-induced toxicity not only to HT22 cells but also to human neurons. Furthermore, we show that safranal reduces ROS, NO and inflammatory molecule levels from amyloid beta-treated astrocytic cells. Importantly, it provides protection to human neurons from the toxic effects of conditioned medium derived from human astrocytes treated with amyloid beta. Thus, safranal protects neurons against amyloid beta-induced direct and indirect toxicity, suggesting that it could be beneficial in the fight against AD.

Indexed as

Amyloid beta-PeptidesCyclohexenesNeuronsNeuroprotective AgentsTerpenesAlzheimer DiseaseAnimalsAstrocytesCell DeathCell LineHippocampusHumansMembrane Potential, MitochondrialMiceNitric OxideReactive Oxygen SpeciesAmyloid beta-PeptidesCyclohexenesNeuroprotective AgentsNitric OxideReactive Oxygen SpeciessafranalTerpenesAlzheimer’s diseaseAmyloid-betaAstrocytesNeuroinflammation and neurotoxicitySafranal

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.